Technology in Diabetes Treatment: Update and Future
Worldwide the number of people with diabetes mellitus is increasing. There are estimations that diabetes is one of the leading causes of death. The most important goals for the treatment of diabetes are self‐management of the disease and an optimal quality of diabetes control. In the therapy new tec...
Gespeichert in:
Veröffentlicht in: | Artificial organs 2018-11, Vol.42 (11), p.1017-1027 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1027 |
---|---|
container_issue | 11 |
container_start_page | 1017 |
container_title | Artificial organs |
container_volume | 42 |
creator | Schiel, Ralf Bambauer, Rolf Steveling, Antje |
description | Worldwide the number of people with diabetes mellitus is increasing. There are estimations that diabetes is one of the leading causes of death. The most important goals for the treatment of diabetes are self‐management of the disease and an optimal quality of diabetes control. In the therapy new technologies, like real‐time continuous interstitial glucose monitoring, continuous subcutaneous insulin infusion (CSII), electronic tools for the monitoring of therapeutic approaches, automated bolus calculators for insulin and electronic tools for education and information of patients, have become widespread and play important roles. All these efforts are related to the interaction between patients, caregivers, scientists or researchers and industry. The presentation of different aspects of new technological approaches in the present article should give more information about different technologies. However, because of the rather quickly appearance of new technologies, the presentation can only be a spotlight. Further studies are mandatory to analyze the effects and long‐term benefits of each technology and electronic device. |
doi_str_mv | 10.1111/aor.13296 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2122578236</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2137405709</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3536-19b2f3de8b8263a95940e950ba4cc9dc46173dade0ce037442e7815b6960c393</originalsourceid><addsrcrecordid>eNp1kM1Kw0AURgdRbK0ufAEJuNFF2vlPxl2pVoVCQSK4GyaTW01JkzqTIH17p0ZdCN7N3RwOHwehc4LHJNzENG5MGFXyAA2JoCImQvFDNMRE4lhI_jJAJ96vMcYJx_IYDRhmjIuUDhHLwL7VTdW87qKyjm5Lk0MLPsocmHYDdXsTPW8L00Jk6iKad23n4BQdrUzl4ez7j1A2v8tmD_Fief84my5iywSTMVE5XbEC0jylkhkVNmFQAueGW6sKyyVJWGEKwBYwSzinkKRE5FJJbJliI3TVa7euee_At3pTegtVZWpoOq8poVQkKWUyoJd_0HXTuTqMC1RQY5HgvfC6p6xrvHew0ltXbozbaYL1PqQOIfVXyMBefBu7fAPFL_lTLgCTHvgoK9j9b9LT5VOv_AT4uHnb</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2137405709</pqid></control><display><type>article</type><title>Technology in Diabetes Treatment: Update and Future</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Schiel, Ralf ; Bambauer, Rolf ; Steveling, Antje</creator><creatorcontrib>Schiel, Ralf ; Bambauer, Rolf ; Steveling, Antje</creatorcontrib><description>Worldwide the number of people with diabetes mellitus is increasing. There are estimations that diabetes is one of the leading causes of death. The most important goals for the treatment of diabetes are self‐management of the disease and an optimal quality of diabetes control. In the therapy new technologies, like real‐time continuous interstitial glucose monitoring, continuous subcutaneous insulin infusion (CSII), electronic tools for the monitoring of therapeutic approaches, automated bolus calculators for insulin and electronic tools for education and information of patients, have become widespread and play important roles. All these efforts are related to the interaction between patients, caregivers, scientists or researchers and industry. The presentation of different aspects of new technological approaches in the present article should give more information about different technologies. However, because of the rather quickly appearance of new technologies, the presentation can only be a spotlight. Further studies are mandatory to analyze the effects and long‐term benefits of each technology and electronic device.</description><identifier>ISSN: 0160-564X</identifier><identifier>EISSN: 1525-1594</identifier><identifier>DOI: 10.1111/aor.13296</identifier><identifier>PMID: 30334582</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Animals ; Blood Glucose - analysis ; Blood Glucose Self-Monitoring - methods ; Calculators ; Diabetes ; Diabetes mellitus ; Diabetes Mellitus - blood ; Diabetes Mellitus - epidemiology ; Diabetes Mellitus - therapy ; Disease control ; Glucose ; Glucose monitoring ; HbA1c ; Hemoglobin ; Humans ; Hypoglycemia ; Hypoglycemic Agents - administration & dosage ; Hypoglycemic Agents - therapeutic use ; Infusions, Subcutaneous ; Insulin ; Insulin - administration & dosage ; Insulin - therapeutic use ; Monitoring ; New technology ; Patient Education as Topic ; Patients ; pump ; Upgrading</subject><ispartof>Artificial organs, 2018-11, Vol.42 (11), p.1017-1027</ispartof><rights>2018 International Center for Artificial Organs and Transplantation and Wiley Periodicals, Inc.</rights><rights>Copyright © 2018 International Center for Artificial Organs and Transplantation and Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3536-19b2f3de8b8263a95940e950ba4cc9dc46173dade0ce037442e7815b6960c393</citedby><cites>FETCH-LOGICAL-c3536-19b2f3de8b8263a95940e950ba4cc9dc46173dade0ce037442e7815b6960c393</cites><orcidid>0000-0002-4115-436X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Faor.13296$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Faor.13296$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30334582$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schiel, Ralf</creatorcontrib><creatorcontrib>Bambauer, Rolf</creatorcontrib><creatorcontrib>Steveling, Antje</creatorcontrib><title>Technology in Diabetes Treatment: Update and Future</title><title>Artificial organs</title><addtitle>Artif Organs</addtitle><description>Worldwide the number of people with diabetes mellitus is increasing. There are estimations that diabetes is one of the leading causes of death. The most important goals for the treatment of diabetes are self‐management of the disease and an optimal quality of diabetes control. In the therapy new technologies, like real‐time continuous interstitial glucose monitoring, continuous subcutaneous insulin infusion (CSII), electronic tools for the monitoring of therapeutic approaches, automated bolus calculators for insulin and electronic tools for education and information of patients, have become widespread and play important roles. All these efforts are related to the interaction between patients, caregivers, scientists or researchers and industry. The presentation of different aspects of new technological approaches in the present article should give more information about different technologies. However, because of the rather quickly appearance of new technologies, the presentation can only be a spotlight. Further studies are mandatory to analyze the effects and long‐term benefits of each technology and electronic device.</description><subject>Animals</subject><subject>Blood Glucose - analysis</subject><subject>Blood Glucose Self-Monitoring - methods</subject><subject>Calculators</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Diabetes Mellitus - blood</subject><subject>Diabetes Mellitus - epidemiology</subject><subject>Diabetes Mellitus - therapy</subject><subject>Disease control</subject><subject>Glucose</subject><subject>Glucose monitoring</subject><subject>HbA1c</subject><subject>Hemoglobin</subject><subject>Humans</subject><subject>Hypoglycemia</subject><subject>Hypoglycemic Agents - administration & dosage</subject><subject>Hypoglycemic Agents - therapeutic use</subject><subject>Infusions, Subcutaneous</subject><subject>Insulin</subject><subject>Insulin - administration & dosage</subject><subject>Insulin - therapeutic use</subject><subject>Monitoring</subject><subject>New technology</subject><subject>Patient Education as Topic</subject><subject>Patients</subject><subject>pump</subject><subject>Upgrading</subject><issn>0160-564X</issn><issn>1525-1594</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kM1Kw0AURgdRbK0ufAEJuNFF2vlPxl2pVoVCQSK4GyaTW01JkzqTIH17p0ZdCN7N3RwOHwehc4LHJNzENG5MGFXyAA2JoCImQvFDNMRE4lhI_jJAJ96vMcYJx_IYDRhmjIuUDhHLwL7VTdW87qKyjm5Lk0MLPsocmHYDdXsTPW8L00Jk6iKad23n4BQdrUzl4ez7j1A2v8tmD_Fief84my5iywSTMVE5XbEC0jylkhkVNmFQAueGW6sKyyVJWGEKwBYwSzinkKRE5FJJbJliI3TVa7euee_At3pTegtVZWpoOq8poVQkKWUyoJd_0HXTuTqMC1RQY5HgvfC6p6xrvHew0ltXbozbaYL1PqQOIfVXyMBefBu7fAPFL_lTLgCTHvgoK9j9b9LT5VOv_AT4uHnb</recordid><startdate>201811</startdate><enddate>201811</enddate><creator>Schiel, Ralf</creator><creator>Bambauer, Rolf</creator><creator>Steveling, Antje</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-4115-436X</orcidid></search><sort><creationdate>201811</creationdate><title>Technology in Diabetes Treatment: Update and Future</title><author>Schiel, Ralf ; Bambauer, Rolf ; Steveling, Antje</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3536-19b2f3de8b8263a95940e950ba4cc9dc46173dade0ce037442e7815b6960c393</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Animals</topic><topic>Blood Glucose - analysis</topic><topic>Blood Glucose Self-Monitoring - methods</topic><topic>Calculators</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Diabetes Mellitus - blood</topic><topic>Diabetes Mellitus - epidemiology</topic><topic>Diabetes Mellitus - therapy</topic><topic>Disease control</topic><topic>Glucose</topic><topic>Glucose monitoring</topic><topic>HbA1c</topic><topic>Hemoglobin</topic><topic>Humans</topic><topic>Hypoglycemia</topic><topic>Hypoglycemic Agents - administration & dosage</topic><topic>Hypoglycemic Agents - therapeutic use</topic><topic>Infusions, Subcutaneous</topic><topic>Insulin</topic><topic>Insulin - administration & dosage</topic><topic>Insulin - therapeutic use</topic><topic>Monitoring</topic><topic>New technology</topic><topic>Patient Education as Topic</topic><topic>Patients</topic><topic>pump</topic><topic>Upgrading</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schiel, Ralf</creatorcontrib><creatorcontrib>Bambauer, Rolf</creatorcontrib><creatorcontrib>Steveling, Antje</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Artificial organs</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schiel, Ralf</au><au>Bambauer, Rolf</au><au>Steveling, Antje</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Technology in Diabetes Treatment: Update and Future</atitle><jtitle>Artificial organs</jtitle><addtitle>Artif Organs</addtitle><date>2018-11</date><risdate>2018</risdate><volume>42</volume><issue>11</issue><spage>1017</spage><epage>1027</epage><pages>1017-1027</pages><issn>0160-564X</issn><eissn>1525-1594</eissn><abstract>Worldwide the number of people with diabetes mellitus is increasing. There are estimations that diabetes is one of the leading causes of death. The most important goals for the treatment of diabetes are self‐management of the disease and an optimal quality of diabetes control. In the therapy new technologies, like real‐time continuous interstitial glucose monitoring, continuous subcutaneous insulin infusion (CSII), electronic tools for the monitoring of therapeutic approaches, automated bolus calculators for insulin and electronic tools for education and information of patients, have become widespread and play important roles. All these efforts are related to the interaction between patients, caregivers, scientists or researchers and industry. The presentation of different aspects of new technological approaches in the present article should give more information about different technologies. However, because of the rather quickly appearance of new technologies, the presentation can only be a spotlight. Further studies are mandatory to analyze the effects and long‐term benefits of each technology and electronic device.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>30334582</pmid><doi>10.1111/aor.13296</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0002-4115-436X</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0160-564X |
ispartof | Artificial organs, 2018-11, Vol.42 (11), p.1017-1027 |
issn | 0160-564X 1525-1594 |
language | eng |
recordid | cdi_proquest_miscellaneous_2122578236 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Animals Blood Glucose - analysis Blood Glucose Self-Monitoring - methods Calculators Diabetes Diabetes mellitus Diabetes Mellitus - blood Diabetes Mellitus - epidemiology Diabetes Mellitus - therapy Disease control Glucose Glucose monitoring HbA1c Hemoglobin Humans Hypoglycemia Hypoglycemic Agents - administration & dosage Hypoglycemic Agents - therapeutic use Infusions, Subcutaneous Insulin Insulin - administration & dosage Insulin - therapeutic use Monitoring New technology Patient Education as Topic Patients pump Upgrading |
title | Technology in Diabetes Treatment: Update and Future |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T00%3A59%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Technology%20in%20Diabetes%20Treatment:%20Update%20and%20Future&rft.jtitle=Artificial%20organs&rft.au=Schiel,%20Ralf&rft.date=2018-11&rft.volume=42&rft.issue=11&rft.spage=1017&rft.epage=1027&rft.pages=1017-1027&rft.issn=0160-564X&rft.eissn=1525-1594&rft_id=info:doi/10.1111/aor.13296&rft_dat=%3Cproquest_cross%3E2137405709%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2137405709&rft_id=info:pmid/30334582&rfr_iscdi=true |